Wolfram Syndrome protein, Miner1, regulates sulphydryl redox status, the unfolded protein response, and Ca2+ homeostasis

Abstract

Miner1 is a redox-active 2Fe2S cluster protein. Mutations in Miner1 result in Wolfram Syndrome, a metabolic disease associated with diabetes, blindness, deafness, and a shortened lifespan. Embryonic fibroblasts from Miner1(-/-) mice displayed ER stress and showed hallmarks of the unfolded protein response. In addition, loss of Miner1 caused a depletion of ER Ca(2+) stores, a dramatic increase in mitochondrial Ca(2+) load, increased reactive oxygen and nitrogen species, an increase in the GSSG/GSH and NAD(+)/NADH ratios, and an increase in the ADP/ATP ratio consistent with enhanced ATP utilization. Furthermore, mitochondria in fibroblasts lacking Miner1 displayed ultrastructural alterations, such as increased cristae density and punctate morphology, and an increase in O2 consumption. Treatment with the sulphydryl anti-oxidant N-acetylcysteine reversed the abnormalities in the Miner1 deficient cells, suggesting that sulphydryl reducing agents should be explored as a treatment for this rare genetic disease.

DOI: 10.1002/emmm.201201429

Extracted Key Phrases

7 Figures and Tables

020040060080020132014201520162017
Citations per Year

1,209 Citations

Semantic Scholar estimates that this publication has 1,209 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@inproceedings{Wiley2013WolframSP, title={Wolfram Syndrome protein, Miner1, regulates sulphydryl redox status, the unfolded protein response, and Ca2+ homeostasis}, author={Sandra E. Wiley and Alexander Yu Andreyev and Ajit S Divakaruni and Robert Karisch and Guy A Perkins and Estelle A. Wall and Peter van der Geer and Yifan Chen and Ting-Fen Tsai and Melvin I. Simon and Benjamin G . Neel and Jack E. Dixon and Anne N Murphy}, booktitle={EMBO molecular medicine}, year={2013} }